Clinical trial
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating…
NCT00002810 · Temple University, Other · Completed
Key facts
| NCT number | NCT00002810 |
|---|---|
| Title | High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis |
| Official title | Autologous Peripheral Blood Stem Cell Transplantation With High Dose Melphalan For Treatment Of Primary Amyloidosis (AL) |
| Lead sponsor | Temple University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, melphalan, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Start date | May 1, 1996 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 1, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: